Skip Navigation



ToxSci Advance Access published online on December 22, 2003
Toxicological Sciences, doi:10.1093/toxsci/kfh021
Toxicological Sciences © Society of Toxicology 2003; all rights reserved
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
77/2/280    most recent
kfh021v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Stickler, M.
Right arrow Articles by Harding, F. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stickler, M.
Right arrow Articles by Harding, F. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Received August 3, 2003; accepted October 13, 2003
© 2003 Society of Toxicology

Immunotoxicology

An in Vitro Human Cell-Based Assay to Rank the Relative Immunogenicity of Proteins

Marcia Stickler 1, Narapon Rochanayon 1, O. Jennifer Razo 1, Jeanette Mucha 1, Wendy Gebel 1, Nargol Faravashi 1, Regina Chin 1, Susan Holmes 2, and Fiona A. Harding 1*

1 Genencor International, Palo Alto, CA 94304
2 Department of Statistics, Stanford University, Stanford, CA 94305

* To whom correspondence should be addressed. E-mail: fharding{at}genencor.com.


  Abstract

A method to rank proteins based on their relative immunogenicity has been devised. A statistical analysis of peptide-specific responses in large human donor pools provides a structure index value metric that ranked four industrial enzymes in the order determined by both mouse and guinea pig exposure models. The ranking method also compared favorably to human sensitization rates measured in occupationally exposed workers. Structure index values for other proteins known to cause immune responses in humans were also determined, and found to be higher than the value determined for human {beta}2-microglobulin. Using values from known immunogenic and putative non-immunogenic proteins, a cut-off value was established. The structure index value calculation provides a comparative method to predict subsequent immunogenicity on a human population basis without the need to use animal models. Information provided by this assay can be used in the early development of protein therapies and other protein-based applications to select or create reduced immunogenicity variants.

Key Words: Immunogenicity, cellular activation, human, antigen/peptide/epitopes .


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
D. Scholl and D. W. Martin Jr.
Antibacterial Efficacy of R-Type Pyocins towards Pseudomonas aeruginosa in a Murine Peritonitis Model
Antimicrob. Agents Chemother., May 1, 2008; 52(5): 1647 - 1652.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.